Method for treating cancer using camptothecin derivatives and 5-fluorouracil
US6794370B2 · kind B2 · utility
85Cited by
1References
7Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Apr 18, 2002 |
| Grant date | Sep 21, 2004 |
| Priority date | — |
| Expiry date | Apr 21, 2022 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P35/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A combination therapy for treating cancer including administering at least one camptothecin derivative in conjunction with another anticancer agent. The combination therapy is preferably used as a first-line therapy for treating metastatic colorectal cancer and preferably involves administration of a combination of CPT-11, 5-fluorouracil and folinic acid, according to specific infusional treatment schedules which show therapeutic synergy in the treatment of cancer.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.